Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Regulation of VEGFR2 and AKT signaling by Musashi-2 in lung cancer.
Journal: bioRxiv : the preprint server for biology
Published: April 10, 2023
Regulation of VEGFR2 and AKT Signaling by Musashi-2 in Lung Cancer.
Journal: Cancers
Published: March 29, 2023
Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC).
Journal: Oncogenesis
Published: January 21, 2021
Case report: reinitiating pembrolizumab treatment after small bowel perforation.
Journal: BMC cancer
Published: September 03, 2018
Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 30, 2016
Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 09, 2016
A Novel HSP90 Inhibitor-Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 21, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026